Exact Sciences Corporation

EXAS

$59.71

Name : Exact Sciences Corporation

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $11,304,243,200.00

EPSttm : -5.45

Exact Sciences Corporation

$59.71

3.39%

$1.96

Float Short %

4.33

Margin Of Safety %

-32

Put/Call OI Ratio

0.72

EPS Next Q Diff

0.08

EPS Last/This Y

5.95

EPS This/Next Y

0.72

Price

57.7

Target Price

66.7

Analyst Recom

1.36

Performance Q

4.41

Relative Volume

0.66

Beta

1.33

Ticker: EXAS

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	EXAS	53.89	0.67	0.59	54914
2025-09-09	EXAS	55.4	0.67	0.94	55033
2025-09-10	EXAS	54.77	0.68	0.95	55479
2025-09-11	EXAS	56.01	0.69	0.44	55663
2025-09-12	EXAS	53.94	0.69	0.06	56297
2025-09-15	EXAS	53.43	0.68	0.39	55974
2025-09-16	EXAS	52.91	0.68	0.39	57362
2025-09-17	EXAS	52.38	0.67139918291658	0.43888070692194	57685
2025-09-18	EXAS	53.59	0.67	0.48	58118
2025-09-22	EXAS	53.56	0.70	0.09	45556
2025-09-23	EXAS	52.41	0.68	0.33	46476
2025-09-24	EXAS	53.14	0.68	0.10	46563
2025-09-25	EXAS	53.68	0.67	0.22	47370
2025-09-26	EXAS	53.54	0.67	2.40	47473
2025-09-29	EXAS	53.38	0.68	0.69	47074
2025-09-30	EXAS	54.74	0.69	0.46	47615
2025-10-01	EXAS	56.43	0.69	0.31	48036
2025-10-02	EXAS	56.22	0.69	0.23	48604
2025-10-03	EXAS	56.71	0.68	1.25	49362
2025-10-06	EXAS	57.63	0.73	0.36	48553
2025-10-07	EXAS	57.7	0.72	0.08	48780
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	EXAS	53.89	226.5	1166.8	0.36
2025-09-09	EXAS	55.41	226.5	1171.2	0.36
2025-09-10	EXAS	54.78	226.5	1164.7	0.36
2025-09-11	EXAS	56.00	226.5	1170.2	0.36
2025-09-12	EXAS	53.93	226.5	1160.5	0.36
2025-09-15	EXAS	53.41	226.5	1164.9	0.36
2025-09-16	EXAS	52.94	226.5	1165.0	0.36
2025-09-17	EXAS	52.35	226.5	1164.7	0.36
2025-09-18	EXAS	53.58	226.5	1170.4	0.36
2025-09-19	EXAS	53.32	226.5	1165.7	0.36
2025-09-22	EXAS	53.56	226.5	1167.2	0.36
2025-09-23	EXAS	52.40	226.5	1163.0	0.36
2025-09-24	EXAS	53.13	226.5	1168.8	0.36
2025-09-25	EXAS	53.68	226.5	1168.3	0.36
2025-09-26	EXAS	53.57	226.5	1166.2	0.36
2025-09-29	EXAS	53.37	226.5	1165.9	0.36
2025-09-30	EXAS	54.71	226.5	1170.6	0.36
2025-10-01	EXAS	56.42	226.5	1171.7	0.36
2025-10-02	EXAS	56.08	226.5	1165.5	0.36
2025-10-03	EXAS	56.70	226.5	1168.0	0.36
2025-10-06	EXAS	57.64	226.5	1170.8	0.36
2025-10-07	EXAS	57.70	226.5	1166.7	0.36
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	EXAS	-0.18	-2.40	5.07
2025-09-09	EXAS	-0.18	-2.40	5.07
2025-09-10	EXAS	-0.18	-2.40	5.07
2025-09-11	EXAS	-0.18	-2.40	3.93
2025-09-12	EXAS	-0.18	-2.40	3.93
2025-09-15	EXAS	-0.18	-2.52	3.93
2025-09-16	EXAS	-0.18	-2.52	3.93
2025-09-17	EXAS	-0.18	-2.52	3.93
2025-09-18	EXAS	-0.18	-2.52	3.93
2025-09-19	EXAS	-0.18	-2.52	3.93
2025-09-22	EXAS	-0.18	-6.35	3.93
2025-09-23	EXAS	-0.18	-6.35	3.93
2025-09-24	EXAS	-0.18	-6.35	3.93
2025-09-25	EXAS	-0.18	-6.35	4.33
2025-09-26	EXAS	-0.18	-6.35	4.33
2025-09-29	EXAS	-0.18	-6.33	4.33
2025-09-30	EXAS	-0.18	-6.33	4.33
2025-10-01	EXAS	-0.18	-6.33	4.33
2025-10-02	EXAS	-0.18	-6.33	4.33
2025-10-03	EXAS	-0.18	-6.33	4.33
2025-10-06	EXAS	-0.18	-5.75	4.33
2025-10-07	EXAS	-0.18	-5.75	4.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.1

Avg. EPS Est. Current Quarter

0.16

Avg. EPS Est. Next Quarter

0.18

Insider Transactions

-0.18

Institutional Transactions

-5.75

Beta

1.33

Average Sales Estimate Current Quarter

810

Average Sales Estimate Next Quarter

827

Fair Value

39.3

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

63.8

Max Drawdown 5-Year %

-80.4

Target Price

66.7

P/E

Forward P/E

110.6

PEG

P/S

3.72

P/B

4.43

P/Free Cash Flow

64.46

EPS

-5.42

Average EPS Est. Cur. Y

0.36

EPS Next Y. (Est.)

1.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-34.19

Relative Volume

0.66

Return on Equity vs Sector %

-65.9

Return on Equity vs Industry %

-51.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1166.7

Exact Sciences Corporation

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 6900

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

stock quote shares EXAS – Exact Sciences Corporation Stock Price stock today

news today EXAS – Exact Sciences Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch EXAS – Exact Sciences Corporation yahoo finance google finance

stock history EXAS – Exact Sciences Corporation invest stock market

stock prices EXAS premarket after hours

ticker EXAS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EXAS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y